Drug Type Herbal medicine |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Phase 2 | United States | 01 Mar 2021 | |
| Arthritis, Reactive | Phase 2 | United States | 01 Mar 2021 | |
| Bipolar Disorder | Phase 2 | United States | 01 Mar 2021 | |
| COVID-19 | Phase 2 | United States | 01 Mar 2021 | |
| Depressive Disorder | Phase 2 | United States | 01 Mar 2021 | |
| Encephalomyelitis, Acute Disseminated | Phase 2 | United States | 01 Mar 2021 | |
| Gastroesophageal Reflux | Phase 2 | United States | 01 Mar 2021 | |
| Glomerulonephritis | Phase 2 | United States | 01 Mar 2021 | |
| Guillain-Barre Syndrome | Phase 2 | United States | 01 Mar 2021 | |
| Hepatitis | Phase 2 | United States | 01 Mar 2021 |





